Return to List

Study Summary
No. 2003-1067:.......Colorectal......James L. Abbruzzese......Gastrointestinal/Digestive Diseases
.
Study Summary Title
Study Summary
Number:		2003-1067
Study Title:A Phase II Multicenter Single Arm Clinical Trial of ABX-EGF Monotherapy in Subjects with Metastatic Colorectal Cancer Following Treatment with Fluoropyrimidine, Irinotecan and Oxaliplatin Chemotherapy
.
Physician New Patient Referral
Name:James L. AbbruzzesePatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:Gastrointestinal/Digestive DiseasesReferring MD
Call:		800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-792-7770
Contact us about clinical trials
.
General Information
Disease Group:ColorectalSupported By:Immunex Corporation
Phase of Study:Phase IIReturn
Visit:		Patients must come to MDACC every two weeks for ABX-EGF infusion.
Treatment
Agents:		Biopsy
Collection
Imaging
ABXEGF		Home Care:Study Tests and evaluations will be performed at MDACC.
Treatment Loc:outpatient
Estimated
Length of Stay
in Houston:		Hospitalization is not required for this study
Description/
Intervention:		Unavailable
.
Study Objectives / Outcomes
Unavailable
.
Study Status Information
Study Activation / Registration Date:09/01/2004
IRB Review and Approval Date:02/18/2004
Study Type:Therapeutic
Recruitment Status:Closed
Projected Accrual:15
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.
Inclusion Criteria:Unavailable
.
Links
Registration Number:
Other Links:
.
Results

Return to Clinical Trials at M.D. Anderson Cancer Center